# Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS

- Source: PR Newswire M&A
- Published: 2026-10-30T17:39:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/stryker-nyse-syk-scrutinized-amid-disclosure-of-persisting-peripheral-vascular-problems----hbss-302925082.html
- Canonical: https://groundlevelnews.com/story/stryker-nyse-syk-scrutinized-amid-disclosure-of-persisting-peripheral--d57cae/

SAN FRANCISCO, Oct. 30, 2026 /PRNewswire/ -- On September 8, 2026, investors in Stryker Corporation (NYSE: SYK) saw the price of their shares fall $26.70 (-8.8%) after the company's CFO revealed that a previously-thought resolved manufacturing issue persists. The move lower wiped out over...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._